Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms

Area of Science:

• Neuroscience
• Pathology
• Genetics

Background:

• Tau protein normally stabilizes microtubules but aggregates when hyperphosphorylated in neurodegenerative diseases.
• Hyperphosphorylated tau accumulation causes neuronal toxicity, leading to tauopathies such as Alzheimer's disease (AD).
• Tau pathology is increasingly linked to epilepsy and network hyperexcitability in various neurological conditions.

Purpose of the Study:

• To investigate the complex relationship between tauopathies and seizure disorders.
• To explore potential shared upstream or feedforward mechanisms driving these comorbidities.
• To identify novel therapeutic strategies targeting both epileptogenesis and cognitive decline.

Main Methods:

• Literature review of studies examining tauopathy and epilepsy comorbidities.
• Analysis of mechanisms involving tau kinases, phosphatases, and mTOR signaling.
• Exploration of specific neurological disorders with co-occurring tauopathy and epilepsy.

Main Results:

• Tau aggregation and hyperphosphorylation are associated with epilepsy and network hyperexcitability.
• Targeting tau phosphorylation or levels can reduce seizure activity and hyperexcitability.
• Convergent, feedforward, or coincident mechanisms may underlie the tauopathy-epilepsy comorbidity.

Conclusions:

• The interplay between tau pathology and epilepsy is multifaceted, involving shared molecular pathways.
• Understanding these mechanisms could reveal new therapeutic targets for conditions like Alzheimer's disease and epilepsy.
• Further research into tau kinases, phosphatases, and mTOR is crucial for developing effective treatments.